« January 2005 | Main | March 2005 »

February 28, 2022

Plastic Manufacturing Experts Launch Consulting Business for the Medical Supply Industry

As a niche consulting firm, Austoah Manufacturing provides targeted solutions and support for pharmaceutical and medical device companies looking to outsource their project management needs.

Matthews, NC (PRWEB via PR Web Direct) February 28, 2022 -- Austoah Manufacturing announced the launch of their new plastic’s consulting business for the medical and life sciences industries. Founded by Marc and Shannon Norman, Austoah offers pharmaceutical companies and medical device manufacturers a comprehensive package of consulting services to meet their project management needs. "Our experience in this industry has taught us that a quality plastic product must be supported with knowledgeable and dedicated management."

Austoah provides consulting services in all areas of plastics covering everything from idea, design, development and production. Their experts can assist with material specification and analysis, failure analysis and reliability, part design and analysis, tooling design and analysis, process development and analysis, training and troubleshooting. Having this broad area of expertise ensures that Austoah can meet the comprehensive needs of all their clients.

Meeting those needs includes offering project evaluation and leadership services. Companies who purchase large quantities of a particular plastic product may be able to save thousands to hundreds of thousands of dollars in purchasing costs by manufacturing the product themselves. Austoah can evaluate the existing product, perform the necessary research and then lead the production process for the company. According to Mr. Norman, "Most of the time small modifications can be made to the product to allow independent manufacturing of the item. When spending millions of dollars on such products, we can assist in identifying cost-saving options."

As project team leaders, Austoah ensures that supplier errors are kept to a minimum. Monitoring implementation of first-articles or standard operating procedures, data acquisition, measurements, documentation tracking, sampling data, tool validation, and revision control are critical activities that Austoah oversees as part of its project management process. This promotes a smooth transition for the overall manufacturing process and supports their client’s need to get accurate and cost-effective results.

The principal consultant, Marc Norman, has over 15 years of experience in the plastic manufacturing industry covering the areas of injection molding, product sampling, verification of automation, material research and testing, and training of suppliers. Mr. Norman has the hands on experience, education and resources that are demanded of an expert in this field. His proven success record includes managing projects for clients such as Schering Plough, Baxter Medical, Medtronics, Gelman, Abbott, Eli Lilly, Johnson and Johnson, Hufriedy, Glaxo, 3M. Carbomedic and many others.

In addition to consulting services, Austoah has also launched the first of its own products for the medical and life science industry. They are offering high quality, polypropylene boxes for storage of 15 ml and 50 ml laboratory tubes. The storage boxes are ideal for storing and transporting tubes in the laboratory or hospital setting. The storage boxes can be maintained under refrigeration or freezing conditions. They can also withstand autoclaving conditions without any damage. These storage boxes can be used to replace the standard cardboard box utilized in many laboratories today. According to the Normans’, "Cardboard boxes can cause particulates and higher mold counts in lab environments. These plastic storage boxes alleviate this contamination problem." Moreover, when cardboard boxes become wet, they break down and lose their shape eventually requiring them to be thrown out. This means that labs are continuously purchasing new cardboard boxes to replace the worn out ones. This expense and wasted time can be avoided by using Austoah’s plastic storage boxes. For more information on these storage boxes, visit http://www.austoah.com/page2.html

About Austoah Manufacturing
Founded in 2004, Austoah Manufacturing, Inc. provides consulting services specifically for medical plastic manufacturing. Their clients include pharmaceutical and medical device companies who outsource plastic components as part of their product development and manufacturing processes. For more information, please visit http://www.austoah.com

Contact Information:
Marc Norman
Austoah Manufacturing, Inc.
704-506-7378
http://www.austoah.com

Posted by Industrial at 11:39 PM | Comments (0)

Nena Jukes Appointed Main Course Tutor at the Central London College of Reflexology ( CLCR )

Nena Jukes DPodM MAR has been elevated to the position of Main Course Tutor at the Central London College of Reflexology ( CLCR )

(PRWEB) February 28, 2022 -- It has been confirmed that Nena Jukes DPodM MAR has been elevated to the position of Main Course Tutor at the Central London College of Reflexology ( CLCR ) This follows comprehensive appraisal by the Association of Reflexologists (UK) and takes immediate effect. Nena is a trained Podiatrist in Suffolk and graduated in 1985 from the London School of Podiatric Medicine.

Nena worked as a Clinical Tutor at Sussex School of Podiatry from 1986-1989 and then completed her Reflexology Training at CLCR in 1996 whilst working as a Podiatrist within the NHS and private sector. Nena now has a Private Reflexology Clinic and also runs Reflexology Courses in Eye (A Village in Suffolk), and also lectures Physicians and Surgeons on wound management in diabetes.

About Central London College of Reflexology (CLCR):
London College of Reflexology ( CLCR )is one of the longest established Reflexology Schools in the United Kingdom , with a Solid International Base.

LCR was established in early 1989 to effectively train and mentor Independent Practitioners of Reflexology to the Highest Professional Standards. Our Core Curriculum currently meets (and possibly exceeds) the Foundation Requirements set out by the House of Lords Report (2000) on Complementary and Alternative Medicine (CAM), and the Reflexology Forum.

This will ensure that all CLCR Graduates will be appropriately qualified to take full advantage of New Career Opportunities which are swiftly becoming available to Reflexologists all over the globe ,as the World moves towards a more Integrated Approach to Healthcare Delivery. We have consistently gained a highly unique reputation for providing one of the World's most Comprehensive, Ethical, Professional, Informative and Cost-Effective Reflexology Courses available.

Our 'Tailored' Government-Approved (ABC) Diploma Courses in Reflexology are held over nine months and on graduation LCR Practitioners in Reflexology will be eligible to join the Association of Reflexologists (AoR), becoming entitled to use the letters MAR after their names.

Additionally,Central London College of Reflexology( CLCR ) is currently the only Accredited Training Institution by the Faculty of Refloxology (FoR) ; an International Caucus of Seasoned Consultants in Advanced Reflexology. In most European Countries and International States which reciprocally recognise British Qualifications, most CLCR graduates should not have difficulty integrating seamlessly into their own Local Healthcare Systems.

CLCR Graduates will also (subject to satisfactory conditions) be ethically listed on an International Referral Database, which is continuously updated and made freely available globally to the Medical Profession , Qualified Healthcare Practitioners and other members of the public who may wish to seek the services of Qualified Reflexologists.

CLCR has formidably and flawlessly laid the Selfless Foundations for many other Independent Reflexology Schools to freely model and emulate.

CLCR is fully committed to finding gainful employment for Successful Graduates in various organizations like Health Clubs, Hotels, Holiday Resorts, Health Farms, Spas, Hospitals, Hospices, Clinics, Elderly Care Homes, Day Centres, Private Health Establishments, Beauty Parlours and many other Institutions.

CLCR is conveniently situated in the heart of Covent Garden in London’s West End and located close to Charing Cross, Leicester Square and Covent Garden Underground Tube Stations.

Understanding Reflexology:
The healing art of Reflexology has been practiced for many thousands of years. One of the earliest recordings of this therapy is a painting within the tomb of the physician in ancient Egypt dated 2300BC and illustrated Reflexology treatments being performed on the feet and hands. When Native Americans practiced a form of Reflexology they believed that energy is exchanged from the earth through the feet and considered how important it is that there are no blockages in the feet to stop this flow of energy.

Contact us at www.reflexologyschool.co.uk for a prospectus.

Posted by Industrial at 10:26 PM | Comments (0)

February 27, 2022

Cleanrooms: A Question & Answer Document from Baxa Corporation

Question & Answer Document from Baxa Corporation is Now Posted on PublicRelationsNewsroom.com for Media and Professional Access In Light of the Continued Regulatory Focus on Hazardous Drug Handling in the Workplace
"Understanding Cleanrooms: Answers to Frequently Asked Questions," authored by Pat Hynes, VP of Global Quality for Metro Denver-based Baxa Corporation is now posted for media and professional access on PublicRelationsNewsroom.com. Since the American Society of Health-System Pharmacists (ASHP) released USP 797 in January 2004 and the National Institute for Occupational Safety and Health (NIOSH) published its 2004 alert on the health risks posed to those working with hazardous drugs, there has been a renewed industry-wide focus on safety within the hospital pharmacy environment. The posted Q&A; is intended to provide a general understanding of what cleanrooms are and how they are monitored.

Englewood, CO (PRWEB) February 27, 2022 – With hazardous drug handling brought to the forefront of public scrutiny in 2004 by the American Society of Health-System Pharmacists (ASHP) USP 797 and a (PRWEB) February 27, 2022 -- related National Institute for Occupational Safety and Health (NIOSH) Alert, Baxa Corporation has published a detailed question and answer document exploring the topic of cleanrooms. The Cleanroom Q&A; is now posted on www.PublicRelationsNewsroom.com (click the Cleanrooms tab) for both professional and media access, according to Greg Baldwin, Chairman and CEO of Baxa Corporation. Baxa is the US distributor of PhaSeal®, the only closed system that prevents the workplace contamination threats as delineated in the NIOSH Alert.

"The USP General Chapter 797 on compounding sterile preparations makes some specific recommendations regarding cleanliness and cleanrooms. While it does not specifically require a cleanroom for sterile compounding, the guideline does require that sterile compounding take place in a separate area that meets a defined level of cleanliness. Many pharmacists have expressed concern about cleanrooms and their requirements in an attempt to clarify the requirements for USP 797 compliance. The discussion now posted on the PublicRelationsNewsroom.com is intended to provide a general understanding of what cleanrooms are and how they are monitored," says Baldwin.

"Understanding Cleanrooms" is found at http://www.publicrelationsnewsroom.com/_wsn/page7.html. This paper is authored by Baxa Corporation’s Pat Hynes, VP of Global Quality.

Hynes has more than 20 year’s experience in quality assurance and regulatory affairs activities. At Baxa Corporation, he has been involved in critical strategic initiatives for adopting lean manufacturing processes and Six Sigma implementation. He is a recognized expert in cleanroom design and requirements both through his work at Baxa Corporation and with COBE Cardiovascular worldwide. Hynes’ previous employment includes positions in new product development, manufacturing management and product evaluation. He was instrumental in the development of Baxa Corporation’s current quality system and is responsible for the enforcement of Quality System Requirements (QSRs). He holds a BS in Biology with a minor in Chemistry.

Baxa Corporation, as mentioned above, offers the only closed system for safe handling of antineoplastic and other hazardous drugs. This system, PhaSeal, uses dry connections and a built-in expansion chamber to prevent drug aerosol leakage and subsequent transfer into the work environment. As a closed system, it contains hazardous drugs throughout the entire process of drug transfer, preparation, transport, administration and disposal - eliminating the risks of environmental and occupational exposure.

The PhaSeal System is currently in use for handling hazardous drugs in more than 200 leading cancer hospitals in the US. The system is also used in progressive hospitals throughout Europe.

A leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa Corporation manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com

The PhaSeal System is manufactured in Sweden by Carmel Pharma ab of Göteborg, Sweden. Introduced in Europe in 1994, the PhaSeal System is now used in most Swedish hospitals, with its benefits documented by a significant body of scientific research on the health risks associated with the preparation and administration of cytotoxic drugs. The PhaSeal System is protected by a comprehensive patent portfolio in the U.S., European Union and Japan. For more information on Carmel Pharma, please visit http://www.carmelpharma.se

Additional resources regarding this subject matter:

UNDERSTANDING USP 797
http://www.publicrelationsnewsroom.com/_wsn/page4.html

ENVIRONMENTAL CONTROLS FOR STERILE COMPOUNDING
http://www.publicrelationsnewsroom.com/_wsn/page6.html

SAFE HANDLING OF HAZARDOUS DRUGS IN THE WORKPLACE: EXPERT PERSPECTIVES
http://www.expert411.com/_wsn/page9.html

"What if the Cure is Also a Cause?
The Same Chemo Drugs That Save Some Cancer Patients' Lives Put Health Workers at Risk"
A MAJOR DAILY NEWSPAPER LOOKS AT THIS ISSUE IN DEPTH: February 15, 2022
http://www.washingtonpost.com/wp-dyn/articles/A24458-2005Feb14.html?referrer=emailarticle

# # #

Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
http://www.baxa.com

Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558
http://www.absolutelypr.com

Posted by Industrial at 09:30 PM | Comments (0)

Baxa Corporation Expands Headquarters Facilities

Baxa Corporation announces the addition of a new building to its corporate headquarters in Metro Denver. The expansion provides a 15,000 square-foot facility accommodating the sales, marketing and technical support operations for the medical device manufacturer. Two years after the company built a state-of-the-art production facility in Englewood, Colorado, unprecedented business growth constrained the office and administration space.

Englewood, CO (PRWEB) February 27, 2022 -- Baxa Corporation announces the addition of a new building to its corporate headquarters. The expansion provides a 15,000 square-foot facility accommodating the sales, marketing and technical support operations for the medical device manufacturer. Two years after the company built a state-of-the-art production facility in Englewood, Colorado, unprecedented business growth constrained the office and administration space.

“We never expected to outgrow the Grasslands facility so quickly,” says Greg Baldwin, Baxa Chairman and CEO. “Our long-term plan is to create a campus with several buildings housing the manufacturing, customer service and support and new product development activities.” Double-digit sales growth moved up the timeline for the addition of office space for the company, which was able to accomplish the planning, building and move in less than six months. “Baxa has a reputation for outstanding customer service. We were fortunate to be able to accomplish the entire project without impacting our customers. Technical support and customer service associates made a smooth transition to the new facility, while day-to-day operations were uninterrupted,” Baldwin adds.

With this office expansion, Baxa Corporation has the space for planned expansion in its hardware and software development teams. As a privately held company, Baxa invests profits in R&D; and new product planning activities, providing significant opportunity for future growth.

Note: The Baxa corporation mailing address (14445 Grasslands Drive, Englewood, Colorado 80112-7062), phone numbers and e-mail addresses remain unchanged with this expansion.

Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Baxa Corporation is privately held, with subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com

For More Information, Contact:
Marian Robinson, Vice President, Marketing, Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Maggie Chamberlin Holben, APR, Absolutely Pubic Relations: 303.984.9801 or 303.669.3558

Posted by Industrial at 09:28 PM | Comments (0)

February 25, 2022

Oxford Performance Materials, Inc. Selects Vaupell as Exclusive Molder of OXPEKK® Implantable Polymer

New relationship allows medical customers to purchase molded implants; expands procurement options for medical OEM's.

Enfield CT (PRWEB) February 25, 2022 -- Oxford Performance Materials, Inc. (OPM) has selected Vaupell as its exclusive molder of its OXPEKK®-IG implant grade polymer. This new relationship expands procurement options for medical OEM’s

“We are very pleased to announce Vaupell as our exclusive US injection molding process partner”, said Scott DeFelice, President of OPM. “Vaupell has a superb national reputation as a molder of high performance polymers as well as extensive experience molding medical implants. From part design, tool design and assembly to packaging, Vaupell offers our customers the type of turn key solution that they find highly desirable.”

“We have watched with keen interest the evolution of OPM. They are bringing excellent products to the marketplace, supporting their offerings with world-class technical support and building true partnerships. I am convinced that the combination of Vaupell’s broad capabilities and OPM’s medical polymer technology will create lasting value”, said Joe Jahn, President of Vaupell.

Vaupell has over 56 years experience in molding advanced polymers for medical and aerospace applications, and is highly qualified to be OPM’s partner for injection molded products. With Class 7 & 8 clean rooms, ISO 13485:2003 and CE certification, Scientific Injection Molding technologies and much more, Vaupell provides a cost-effective source for design, process validation and contract manufacturing of a variety of products. For more information, please visit www.vaupell.com

Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK® polymers are currently being used in space and defense, medical, semiconductor, and industrial markets worldwide. For more information, please visit www.oxfordpm.com

Posted by Industrial at 04:29 AM | Comments (0)

Complete Personal Medical History to be Contained on Device the Size of a Keychain

Aside from all the other benefits, the most basic and essential element of the product is that it is a step towards creating the most accurate and reliable system for storing, organizing and sharing medical record information across the entire Healthcare Continuum.

(PRWEB) February 25, 2022 -- A new product offers relief from the burdens of dealing with medical records and the hassles associated with them. Patient Practitioners, a company out of Chipley, Florida has developed a medical record system that allows for your complete medical history to be contained on a device the size of an average keychain.

This new medical record system can be accessed by any desktop or laptop computer as well as ambulances, making the owners records instantly available. The value of having up-to-date information at a moments notice is almost incalculable in an emergency situation. A Paramedic or EMT would be able to access a patient’s entire medical history before even leaving a crash site. A doctor in the emergency room would be able to quickly treat a patient with their full record at his or her fingertips. This feature would be particularly beneficial to those who are need of specialized treatment, such as diabetics or those unable to take certain medications. For these patients a simple mistake may not be so simple, and the use of such a system can be more than helpful.

Aside from emergency situations the Portable Medical Record System also makes standard doctor visits easier on both parties. The medical record system can be read by almost any medical facility, cutting down on time spent retrieving patient records and allowing for doctors to spend more time with the patient themselves. The patient also doesn’t have to worry themselves with keeping track of numerous medical records as they as can access their records using the system. The program presents the information in a simple and easy to read format that allows for doctor and patient alike to read and understand the information with no confusion. This is also the case for when adding information to the system.

The system is able to store basic medical record information as well as the patient’s family medical history. The system also can hold the patient’s dental records, immunization history, blood type, organ donor information, next of kin contacts, known allergens, and genetic test results. All the information on the unit can be translated into 3 different languages. At the click of a button the records on the unit will be available in English, Spanish, or French. This feature is very useful for those who travel, offering a degree of security when in a foreign land. The products small size makes carrying your records an easy task. You can carry the device on your keychain or wear it as a necklace.
The company is also planning a line of jewelry integrating the device.

The benefits of this product extend past just accessibility and convenience. The product is also useful in cases of malpractice, fraud, and insurance matters. The product utilizes bio-metric security using encryption technology to secure the patients privacy, as well as preventing any unlawful access of the medical records contained on the unit. The product can also provide accurate photographic identification of the patient in addition to the medical information.

Since cost is always an important factor in any person’s consideration it is useful to know that the medical record device and program used to read it are inexpensive and will aid the patient in saving money on future medical expenses. Use of the product and system helps reduce the cost of delivering healthcare and speed up the insurance claim process.

The advantages of the system extend beyond just the patient; use of the system can also be very useful to medical facilities themselves. Aside from eliminating unnecessary time spent on acquiring records the system also makes compliance with government regulation a much more simple process.

Aside from all the other benefits, the most basic and essential element of the product is that it is a step towards creating the most accurate and reliable system for storing, organizing and sharing medical record information across the entire Healthcare Continuum.

Posted by Industrial at 04:25 AM | Comments (0)

Altimate Medical Introduces the New EasyStand Evolv

Altimate Medical is proud to introduce the new EasyStand Evolv. The EasyStand Evolv is the next generation of the current EasyStand Series. Altimate Medical’s Product Development Team has made significant improvements to the EasyStand based on feedback from customers around the world.

(PRWEB) February 25, 2022 -- Altimate Medical is proud to introduce the new EasyStand Evolv. The EasyStand Evolv is the next generation of the current EasyStand Series. Altimate Medical’s Product Development Team has made significant improvements to the EasyStand based on feedback from customers around the world.

The EasyStand Evolv’s most noteworthy change is in the lifting design which mimics the body’s natural pivot points, minimizing shear. The Evolv’s redesigned modular base allows various options like the sit-to-stand desk, self-propelled mobility, or the “Active Standing” Glider to be added at anytime. Alan Tholkes, President & CEO of Altimate Medical points out, “Previously, our customers had to choose between ordering the EasyStand 5000 and the EasyStand 6000 Glider. With the EasyStand Evolv, our customers can order the Glider option at a later date.”

Transfers into the EasyStand Evolv are easier because of its wider seat and open base, which allow the user’s wheelchair to be positioned closer to the stander. The open base also allows lifts to be used when transferring a person into the stander. Tholkes adds, “The new design and modular options of the EasyStand Evolv will make standing achievable for more people.”

Altimate Medical manufactures standing technology that focuses on health and independence for kids and adults with disabilities. For more information on the new EasyStand Evolv contact Altimate Medical at 800-342-8968 or visit our website at www.easystand.com

*Note to Editors: Other Altimate Medical press releases, background information, and photos are available at www.easystand.com/pressroom

Posted by Industrial at 04:24 AM | Comments (0)

February 24, 2022

Stopping Catheter-Related Urine Infections with Waterfall D-Mann

The product known as 'Waterfall D-Mannose', an extract of fermented larch wood produced by Sweet Cures of York, is proving to be very effective at treating and preventing catheter-related urinary tract infections.

(PRWEB) February 24, 2022 -- After a former staff nurse, Fiona Richardson, who suffers from multiple sclerosis, wrote an article for New Pathways Magazine, [http://www.msrc.co.uk about how Waterfall D-Mannose has changed her life, Sweet Cures has been inundated with self-catheterising customers, some of whom have been plagued with bladder infections for years, despite ongoing antibiotic treatments. Almost all of the customers have reported complete alleviation of symptoms, and are now using Waterfall D-Mannose to prevent new infections.

According to Anna Sawkins, a partner in Sweet Cures, the results have astonished both patients and doctors, and have proved that Waterfall D-Mannose works both to cure catheter-related infections, and prevent reinfection, even in a hospital environment. For example, consultants in Stoke Mandeville Spinal Injuries unit were surprised that a patient who was in for six weeks treatment, and had previously been plagued with bladder infections, had no E.coli or Klebsiella infections during his stay. He had refused antibiotics, since they had previously proven ineffective, and was self-dosing with Waterfall D-Mannose. They have since recommended the product to other patients.

John Bremner, the other partner in Sweet Cures, reinforces the point, “We have doctors passing our leaflets to their patients rather than providing antibiotics, and we have long-term results from many customers who appear to have permanently cured antibiotic-resistant cystitis problems. Our product has been recommended by consultants, gynaecologists, and family doctors, and has proven itself in the real world.”

He quotes a damning Bandolier study of hospital related cystitis:

“About a quarter of hospital patients have a urinary catheter some time during their stay, and an average of 5% (range 3-10%) will acquire a urinary tract infection every day. Clearly, then, almost all patients will have an infection after about a month. This can extend hospital stay by about three extra days, and patients with a urinary tract infection are three times more likely to die. The case-fatality rate from urinary tract related bacteraemia is 13%.” - Bandolier [http://www.jr2.ox.ac.uk/bandolier/band67/b67-4.html

Since Waterfall D-mannose stops urinary tract infections in over 90% of cases, and almost 100% where E.coli is the bacterium concerned, it seems clear that a lot of unnecessary deaths could be prevented if hospitals switched to using Waterfall D-Mannose instead of antibiotics for E.coli related UTIs.

John Bremner points out that it is important to achieve a high enough concentration of the product in the urine. “For catherised patients on constant drain, it may be necessary, when using Waterfall D-mannose, to interrupt the flow of urine for an hour or so by valving the catheter if this is possible. This allows the d-mannose in the urine long enough to interfere with the attachment mechanism of the bacteria. This is not a bad thing, since the bladder shrinks if it never gets the chance to fill, and that can cause its own problems.”

The average treatment dose is 1.6 grams, taken preferably with a warm drink. Trials have shown that an effective concentration in the urine is around 5.5 mg of mannose per millilitre of urine, so it’s better to take the product with 100 to 150ml of fluid, then to wait an hour before drinking another 200 to 300ml

It is particularly interesting to the medical profession that Waterfall D-Mannose works as well on antibiotic-resistant recurrent E.coli infections as it does on fresh infections. “This is because Waterfall D-Mannose works in a completely different way from antibiotics,” Mr Bremner points out.

Effectively, instead of killing the E.coli as antibiotics do, the product uses one of E.coli’s greatest strengths – the ability to attach to the mannose receptors in our cells, as a weapon against it. When you take Waterfall D-Mannose, (it’s a pleasant tasting powder that can be dissolved in a drink), over ninety percent of the mannose consumed is in the urine within an hour. The E.coli latches onto the most easily accessible mannose – the mannose in the urine, rather than the cell walls, bio-molecularly filling up the lectins (the molecular attachment points) that it normally uses to attach to the bladder and urinary tract. Since the mannose attachment is crucial to E.coli and some other bacteria’s ability to attach to cells, the bugs are then flushed away with normal urination. The E.coli that has already managed to attach to the bladder is gradually teased away, providing a full bladder cleanse. This allows the bladder to heal naturally, and since there are no bacteria actually killed in the process, there is no resultant thrush – a common side-effect of using antibiotics.

Interestingly, Waterfall D-Mannose also flushes away ‘debris’ – the broken and empty shells of dead E.coli – one possible cause of the painful bladder syndrome commonly known as interstitial cystitis.

John Bremner explains, “E.coli are bio-molecularly attached to tissue cells in the urinary tract and bladder, so when you kill them with antibiotics, the molecular bonds are not broken – it’s not as if they can consciously let go. Waterfall D-Mannose has the ability to break these bonds, and release the debris into the urine where it will be flushed away along with the live E.coli that have their mannose receptors filled with the free mannose in the urine.”

A six month clinical trial conducted by Michael Blue, a Urologist in Oklahoma, has shown good evidence to support this theory.

“Of the 18 PBS females who were treated daily with two scoops of D-Mannose, 17 (94%) reported symptom improvement, the lone exception being a subject unable to be contacted, but also not returning for treatment. Eighty percent became totally symptom free.” [www.healingtherapies.info/D-Mannose.htm

Meanwhile, Sweet Cures has gone from strength to strength. An Italian version of their www.waterfall-d-mannose.com website was recently released, www.waterfall-d-mannose.com/Italy/ and they are working on a Dutch translation next. They also have a major distributor in Austria, and they send the product worldwide to individuals, therapists, health clinics, and doctors.

“The fact is,” says Anna McNamara, “that we have a product that is considerably more effective than antibiotics or any other treatment for E.coli and Klebsiella related UTIs and bladder infections, and also for painful bladder symptoms or interstitial cystitis. No doctor is really happy with giving out antibiotics unnecessarily, but until now they had no choice. Waterfall D-Mannose provides a better, safer, more effective option, and more and more doctors are starting to get behind us, often as a result of their own patients telling them of this quick solution to antibiotic-resistant urine infections.”

Contact Details: Sweet Cures, Raveloe House, 101 Foxwood Lane, York, YO24 3LQ Tel: 01904-340916 www.waterfall-d-mannose.com

Posted by Industrial at 10:50 AM | Comments (0)

Medical Device Industry Experts Partner in Twin Cities Coalition

MDRG Appoints DDL Package Testing Engineer as New VP
Scott Levy, DDL Package Testing Engineer has been appointed Vice President of Twin Cities Based Medical Device Resource Group (MDRG), to build and foster the MDRG’s reputation as a leading industry resource.

Minneapolis, MN (PRWEB) February 24, 2022 -- http://www.testedandproven.com - The Medical Device Resource Group (MDRG), a Twin Cities-based coalition of service providers to medical device companies, has appointed Scott Levy, DDL Inc. Package Testing Engineer, as its new vice president.

The Medical Device Resource Group is a coalition of Twin Cities-based companies that together offer the broad expertise needed to successfully develop and market a medical device. The MDRG helps medical device developers, manufacturers and marketers to find the right partners in order to deliver their medical device to market on schedule.

As a medical device industry expert and MDRG member since the coalition's inception in 2001, Mr. Levy is delighted to have been unanimously elected as vice president.

"I believe in the potential of the MDRG and the powerful direction in which it is heading," said Mr. Levy. "There is enough horsepower and expertise in this group to bring a medical device all the way to market."

As package testing engineer at DDL Inc. testing services, Mr. Levy recognizes the massive growth occurring in the medical device industry. Medical device package testing currently constitutes 80% of DDL's overall package testing business.

"With the implementation of stricter regulations, many medical device manufacturers are struggling to understand what they have to do to validate their packaging," said Mr. Levy. "The MDRG is exactly the resource that medical device manufacturers need in order to grow their awareness of package testing, validation and other industry procedures."

DDL Inc. testing services will be partnering with fellow MDRG members, WebLabel and Quality Tech Services, at the upcoming Healthpack 2005 Tradeshow, where they will be debuting their "don't gamble with your packaging" promotion.

HealthPack 2005, March 23-24, San Antonio,Texas at the Hilton Palacio del Rio. Register here - http://www.healthpack.net/registera.shtml.

About DDL Inc.
DDL offers expert product testing, package testing and material testing services including: Shock testing, vibration testing, tensile testing, leak testing and validation. DDL testing services maintains full service testing labs in Minnesota and California.

Contact DDL at www.TestedandProven.com or call Scott Levy at 952-941-9226 ext.115

About MDRG
The Medical Device Resource Group (MDRG) is a coalition of Twin Cities companies that together offer the broad expertise you need to get new medical devices to market - and support them once they're launched. For more information, visit http://www.medicaldeviceresourcegroup.com

Posted by Industrial at 10:49 AM | Comments (0)

International Pharmaceutical Printing/Packaging Company, Pharmagraphics, Joins the Blue Water Media Family

Pharmagraphics www.pharmagraphics.com takes charge of international printing and packaging for Pharmaceutical and Healthcare manufacturers! This North Carolina based company, offers an array of products to meet the needs of medical product manufacturers.

Washington, DC (PRWEB) February 24, 2022 -- Pharmagraphics came to Blue Water Media www.bluewatermedia.net with a mission for their new website – drive more traffic, increase leads and market. Upon completion, the new design provides:
• Easier maneuverability
• A “call to action” on each page, driving visitors to contact the company directly for more information or product inquiries.
• Clear and condensed content – so the visitor can read the information in a short and concise format.
• New images of all products
• An informative FAQ’s section – answering company/industry related questions.

Pharmagraphics specializes in the complete package: label and insert design and the prototyping of products such as pressure-sensitive roll labels, package outserts and inserts, as well as folding cartons for the pharmaceutical, medical device, and consumer goods industries. The service extends beyond these specialized lines of printing, in which any printed labeling application needing cGMP operations can be assessed and performed by any Pharmagraphics operation. Our services include complete package label and insert design and prototyping. Clients are able to color match their products perfectly and test and evaluate all samples on-line.

The state-of-the-art technology offers easy-to-use, turn-key solutions to the advertising specialty, on-demand printing, and packaging markets that are both environmentally friendly and cost effective. Pharmagraphics’ product line is constantly being innovated and expanded in which to “constantly strive to create and design innovative packaging products, and to re-engineer our current product line to suit the individual packaging requirements of each of our customers.” Pharmagraphics operates seven manufacturing facilities worldwide: three in the United States and four in other countries.

Any type of printed labeling application needing cGMP operations can be assessed and performed by any Pharmagraphics operation because of the standardized converting equipment that Pharmagraphics use.

The Web site designed by local design and marketing company Blue Water Media, www.bluewatermedia.com launched July, 2004

Contact Information:
Pharmagraphics
www.pharmagraphics.com
Ernie Chaplin
508-478-7641

Blue Water Media
Miya Taguchi
www.bluewatermedia.net
202.861.0000

Posted by Industrial at 10:47 AM | Comments (0)

February 22, 2022

Advanced Biological Laboratories SA (ABL, SA) Acquires Majority Control of TherapyEdge Inc

Acquisition Adds Key Biotech Patent and Related Products
ABL to integrate TherapyEdge-HIV product functionality into existing product line and license IP to leading diagnostic and laboratory companies.

Luxembourg and Durham, NC (PRWEB via PR Web Direct) February 22, 2022 -- ABL, SA (A Luxembourg Company) acquired majority control of TherapyEdge Inc.(Durham, NC) and its strategic intellectual property (IP), including seminal patents on computer decision support for treatment of complex diseases. Also acquired is the TherapyEdge-HIV Clinical Decision Support (CDS) and patient management software which offers guidance to physicians and care givers on complex therapies for diseases such as HIV/AIDS, TB, Hepatitis and complex diseases. The financial details of the deal were not disclosed.

ABL has granted exclusive right to sublicense the IP to Evidence Medical (www.evidencemedical.com) and has used the technology to update their widely used ViroScorer HIV resistance interpretation product suite.

Chairman of the Board, Arsene Kronshagen commented “This first acquisition for ABL SA has already proven fruitful with the closing of a major licensing deal with a prominent diagnostic company. This will help drive revenue through licensing of the IP and through the sale of our ViroScore and TherapyEdge products which utilize the patented technology. These products help diagnostic companies differentiate their offerings by providing advanced online services that enable their customers to maximize the use of newly FDA approved genotype tests that are widely available.”

ABL uses the technology in the acquired and updated TherapyEdge-HIV patient management system which is used by doctors at clinics supported by the US President's Emergency Plan For AIDS Relief (PEPFAR) to help manage their patient data and provide integrated reporting directly to USAID. TherapyEdge-HIV has a history of meeting the needs of the medical staff who are treating the disease on the ground while providing real time feedback to many of the donor stakeholders who want to track the effectiveness of their programs.

Hank Head, VP of Business Development, stated, “We see a great potential for the products to significantly improve the quality of care and uptake of HIV Anti-retroviral therapy at many clinics. We are expanding in the areas hardest hit by HIV/AIDS with local reseller partners because building small entrepreneurial businesses helps strengthen the local economies and helps to create a business chain that can stall and eventually reverse the global AIDS pandemic.” ABL has signed on reseller partners in South Africa, and is in talks with partners around the globe. They are currently accepting applications for sales agents and reseller partners.

ABL’s decision support and database products are used in 42 clinics across the globe. Sales include new server and user licenses and recurring product maintenance fees. They plan to complete product expansion this year into new disease areas and new product lines such as the PDA data collection system and additional data mining and analysis tools.

For information about licensing the ABL products or starting a research partnership, please visit www.ablsa.com or email e-mail protected from spam bots.

For information about licensing the ABL intellectual property, please visit ABL’s exclusive licensee, Evidence Medical, at www.evidencemedical.com.

About ABL, SA
For information about ABL, SA and TherapyEdge, Inc. please visit www.ablsa.com/press/te_acq.html

Contact:
Henry Head
919-386-8041

Posted by Industrial at 05:52 PM | Comments (0)

PrevaMedic.com Forms Strategic Alliance To Offer Medical Alert Products

Medical Alert Products For Dangerous Medical And Allergic Conditions
Provider of medical alert products selects primary suppliers.

(PRWEB) February 21, 2022 -- PrevaMedic.com, an online supplier of medical alert jewelry and devices, has strategically aligned itself with two primary suppliers for products. After extensive review the company has selected JewelBasket.com and 911Destiny.com to be its exclusive suppliers of medical alert items.

"We feel that JewelBasket.com and 911Destiny.com can provide the types of medical alert products that will best serve our customers," says Terry McDermott, president of PrevaMedic.com. "These companies offer outstanding variety and excellent quality. Plus, between the two companies, the jewelry items can satisfy almost any budget."

Many medical conditions require some form of identification indicating that such a condition exists and must be considered in the case of an emergency. Thus, millions of people with hundreds of medical conditions must advertise that fact simply to protect themselves. For many, jewelry is the chosen medium.

Fact: Up to 15% of the population of the United States could experience a life-threatening reaction to foods, drugs, insect bites or latex.

Fact: Many diabetics suffering from hypoglycemia (low blood glucose) have been mistakenly identified as being drunk.

Fact: Over 400 Americans die annually from an allergic reaction to penicillin.

Given these and many more related statistics, the need for proper medical identification is critical. But in an image conscious society, clunky bracelets or dog tags may offend the fashion sensibilities of some while the overt labeling of medical conditions may be threatening to others. That is why manufacturers of medical jewelry are looking for a balance between the necessity of clear communications and a desire for attractive accessorizing.

Says Mr. McDermott, "We pride ourselves in offering the most attractive and affordable medical alert jewelry. Just because a person has a potentially dangerous condition does not mean that they have to be stigmatized. Our products allow these individuals to look stylish while adequately protecting themselves."

Posted by Industrial at 04:06 AM | Comments (0)

February 18, 2022

Beasley Allen Calls Upon Merck to Leave Vioxx Off the Market

Experienced lawsuit attorneys have been reviewing patient cases against Merck since 2000. They urge Merck to honor the September 2004 Vioxx recall

Montgomery, AL (PRWEB via PR Web Direct) February 18, 2022 -- Andy Birchfield, lead Vioxx Attorney at Beasley Allen Law Firm, has called upon Merck to do the right thing and leave Vioxx off the market.

An FDA advisory panel voted today (17-16) that Vioxx could be placed back on the market. Merck officials have recently stated that they would consider re-introducing the controversial painkiller to the market based on the FDA panel findings.

Beasley Allen has been watching the situation unfold over the past 4 years. We feel that Merck finally did the right thing in September by withdrawing Vioxx from the market, and to reintroduce the drug now would most certainly result in further cardiovascular injuries, including death. The fact that Merck is even considering putting the pain medication back on the market clearly shows their motives to put profits above people.

When Merck & Co. pulled Vioxx from the market in September, it said it was acting because a clinical trial had shown that users were at increased risk of heart attacks or strokes. Until it pulled the drug last September, Merck defended the painkiller as safe.

Several studies have shown a direct link between Vioxx and increased cardiovascular risk. According to an internal study conducted by FDA scientist Dr. David Graham, up to 140,000 people may have suffered heart attacks as a direct result of taking the pain medication. And millions of people may have been exposed unnecessarily to the risk of heart attack by taking Cox-2 inhibitor drugs, including Vioxx.

Today’s advisory panel vote on Vioxx illustrates the weakness of the current drug control policy and reinforces the need for immediate FDA reform.

For more information:
Andy Birchfield, Attorney
Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.
1-800-898-2034 toll free
1-334-954-7555 fax

Online Media Contact:
Jayme Yarroch
1-800-898-2343 toll free
1-334-657-8959 mobile
Beasley Allen Law Firm
Vioxx Lawsuit Information
beasleyallen.com

Posted by Industrial at 05:04 PM | Comments (0)

February 17, 2022

DISA Vascular’s Small-Vessel Heart Stent Receives European Approval

Medical device company receives CE Mark approval for the cobalt chromium ChromoFlex Micro.

Cape Town, South Africa (PRWEB via PR Web Direct) February 17, 2022 -- Medical device company DISA Vascular (Pty) Ltd today announced European CE Mark approval and market launch of its ChromoFlex Micro stent system for small coronary vessels. This follows CE approval of the large-vessel version, the ChromoFlex, in September 2004

Coronary stents are tiny metallic tubular mesh-like structures which are used to re-open coronary arteries after they have become obstructed by the build-up of plaque. A certain percentage of patients who are treated with stents return with a condition called “restenosis,” a build-up of scar tissue within the stent.

The ChromoFlex range is marketed as a competitive treatment alternative to drug-eluting stents to reduce restenosis.

Similar to the large-vessel ChromoFlex, the new Micro version has ultra thin struts. This feature has been shown to reduce restenosis dramatically in various independent clinical studies. This is made possible by the use of a special cobalt chromium alloy offering numerous advantages over the more conventional stainless steel because of its increased strength and radiographic visibility.

“Since the launch of the ChromoFlex stent in Europe and elsewhere, this product has performed extremely well,” said Dr. Starke, CEO of DISA Vascular. Starke noted that there are currently no cobalt chromium drug eluting stents on the market. DISA Vascular’s own program uses the ChromoFlex as the platform stent. Starke said he felt confident that properly designed cobalt chromium stents used for local drug delivery, such as the ChromoFlex & ChromoFlex Micro, will be markedly easier to deliver and have better clinical outcomes than the stainless steel drug eluting versions currently available.

According to Starke, the new Micro stent, for vessels 2.5 - 3.0mm in diameter, will have even better deliverability features than the large vessel version because of its extremely low profile and high flexibility. Smaller vessel stents are in high demand in Asian and Middle Eastern markets where DISA Vascular has strong market interests.

DISA Vascular (Pty) Ltd is a medical device company, focused on innovative vascular devices for the treatment of heart and peripheral vascular disease.

Contact:
Dr. Gregory Starke
+27 21 4480923
http://www.disavascular.com

Posted by Industrial at 07:30 PM | Comments (0)

At Last, Real Pain Relief for Shingles Patients

Topicure.com released a new patented Over the Counter topical cream treatment for shingles that is changing the way Doctors are treating shingles patients. Topicure Wound Care cream costs $24.95 a tube and brings a new level of treatment with immediate pain relief without having to resort to expensive prescription narcotics.

(PRWEB) February 17, 2022 -- Shingles patients have been suffering from the intense pain of nerve inflammation that could only be treated with narcotic type medications, until now. As shingles patients know, the pain from a shingles episode can last for months and even years. Narcotics can't be used for extended periods of time without addiction. Many shingles patients were seeking relief through home remedies and homeopathic alternatives at considerable cost without success.

A local Denver Doctor is quoted "I have not had a product that I could prescribe for my patiens with shingles that was effective. I can refer my patients to www.topicure.com and feel assured they will receive the pain relief it claims."

One Denver patient stated the benefits clearly, "My Dr. recommended I go to www.topicure.com and I am very pleased with the results. After using Topicure a few hours I was able to switch from taking hydrocodone for the pain to ibuprofen. I could not perform my job with shingles until I found Topicure and then I could function quite well. I would recommend it to all my friends and family." She was thankful her Doctor referred her to their website. The testimonials of praise and thanks are pouring into the Topicure mailbox.

Dr. R.Wilk invented Topicure while practicing in the Dallas Texas area. He retired last May to North Carolina but not before he partnered with SMG Enterprises Inc. to manufacture and distribute his invention. Topicure received its patent in April 2004. Topicure is registered with the FDA and received its NDC numbers in May 2004. Anyone wanting additional information can go to www.topicure.com or call 1-888-378-9412. Their orders are shipped the same day.

Posted by Industrial at 07:29 PM | Comments (0)

February 16, 2022

Oxford Performance Materials, Inc. Selects Medical Device Consultants, Inc. for Regulatory Support Services

OPM clients to benefit from world class regulatory support

Enfield, CT (PRWEB) February 16, 2022 -- Oxford Performance Materials, Inc (OPM) has selected Medical Device Consultants, Inc (MDCI) as its principal regulatory support firm. In this relationship OPM will refer its clients who require regulatory assistance to MDCI. MDCI will also support OPM as it expands its product offerings to the medical device community.

“The advantage of working closely with one regulatory services firm is that both OPM and our clients benefit from the specialized accumulation of knowledge in a single firm”, said Scott DeFelice, President, OPM. “This collaboration results in faster approvals, lower costs and reduced burden on our clients internal staff. We interviewed many prospective firms and established three core requirements. Our partner had to have global capability, be focused on medical devices and be able to offer a broad portfolio of services. Only one firm excelled in these three critical areas and it was MDCI.”

“At MDCI we have a broad vantage into the medical device industry. New materials and technologies are transforming the marketplace. OPM is clearly an innovative firm on the biomaterials frontier and we are pleased to offer both OPM and their clients our many years of accumulated and highly relevant expertise”, said Sheila Hemeon-Heyer, Director of Regulatory Services, MDCI.

Founded in 1980, Medical Device Consultants, Inc. is a leading consulting firm and contract research organization focused on the needs of the medical device, diagnostics, and combination products industries. The company provides regulatory, clinical trial, and quality assurance consulting services to help clients worldwide achieve and maintain compliance with U.S. FDA, Canadian, European, and other international regulations. Please visit us at www.MDCI.com

Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK®-IG polymers are designed to meet the United States FDA requirements for use in long term human implantable medical devices and have been tested in according to ISO-10993. For additional information, please visit www.oxfordpm.com

Posted by Industrial at 02:44 PM | Comments (0)

February 15, 2022

1-diabetes-care.com Launches Diabetic Supply Information Site

Diabetes care is made simple with product reviews and tips on exercise and nutrition.

Las Vegas, NV (PRWEB via PR Web Direct) February 15, 2022 -- 1-diabetes-care.com announces the launch of their diabetic supply website to aid the proper diabetes care essential to maintaining good health and avoiding complications. The site offers product reviews and health articles, providing a broad range of information specifically for diabetes healthcare needs. Visitors may also sign up to receive a free email newsletter at http://www.1-diabetes-care.com

"We are very excited about launching 1-diabetes-care.com knowing that we will be able to provide helpful information to so many people afflicted with diabetes,” said Rob Wiley of 1-diabetes-care.com. “We feel that the increase in diabetes diagnoses should be matched by quality information to benefit all those who have to manage this condition."

There are an innumerable amount of companies that make diabetes care products, each one boasting that it has cornered the market on diabetic care and can offer the most effective tools to manage health. In reality, most diabetic supply companies do offer innovative, effective management tools—from remote control blood meters to less painful lancets—but it is up to the patient to do the legwork to find the products that best fit their needs. The product reviews provided on 1-diabetes-care.com supply customers with the information and resources they need to make healthcare decisions, from blood glucose monitors and insulin pumps to tips on foot care and nutrition.

The site also offers information about the newest technologies and diabetic supplies on the market, and includes links to quality merchants where these supplies can be ordered. The Ascensia® CONTOUR™ blood glucose meter, TheraSense FreeStyle® meter and Medtronic MiniMed Paradigm insulin pump are just a few examples of growth in the diabetic supply industry that adds convenience and ease to the diabetic lifestyle.

Keeping in mind that when armed with the facts, choosing diabetes care products and making healthcare decisions is greatly simplified, 1-diabetes-care.com also offers many other diabetes-related products including short- and long-lasting insulin, glucose tablets to counteract hypoglycemia, diabetes socks and creams to improve circulation, diabetes shoes to prevent foot complications, insulin pump cases, different types of test strips and meters, compression therapy, orthotics, bunion braces and more.

About 1-diabetes-care.com
Located in Las Vegas, Nevada, www.1-diabetes-care.com is an international resource dedicated to the dissemination of all available information related to diabetes. They have a growing archive of over one hundred well-researched articles related to the subject. 1-diabetes-care.com also allows authors to submit articles for review and will consider merchants who offer products relating to diabetes. Please visit http://www.1-diabetes-care.com for more diabetic supply information.

Media Contact:
Rob Wiley
702-990-3868

Posted by Industrial at 04:09 PM | Comments (0)

Nickel Free Fashion Sales on the Rise as Metal Allergy Hits a New High

A growing community of nickel allergy sufferers is giving way to a whole new cottage industry: The nickel free accessory shop.

Los Angeles, CA (PRWEB) February 15, 2022 -— Nickel allergy, already the most common contact allergy in North America, is on the rise. Nickel, found in a wide array of common household objects like eyeglasses, jewelry, belt buckles, and watches, affects approximately 15% of the population. And each year, the population of nickel allergy sufferers seems to grow in size.

Although the use of nickel in jewelry is banned in most of Europe, the United States still has no measure in place to prevent the use of nickel in objects that come into prolonged and intimate contact with the skin. And with nickel allergy affecting approximately 15% of the population, more and more folks with dermatitis are turning over every stone in search of the elusive nickel free belt or watch.

Enter nonickel.com

In 2004, Nonickel.com set out to build the world's first itch-free belt. Since its inception, the site has been a magnate for a growing niche community of metal allergy sufferers looking for hypoallergenic accessories they can wear close to the skin.

"I could find nickel free jewelry online, but no matter how hard I hit the search engines, I could not find nickel free belts, nickel free buckles, or nickel free watches" says Jimmy Sepulveda, a nickel allergy sufferer of 15 years. "I simply avoided belts all-together until my dermatologist recommended the site last month". And more and more dermatologists are spreading the word.

Nonickel.com is targeting dermatologists and their patients this month, to let allergy patients know they can wear a watch or a belt without the itch. And allergy patients are responding. Nonickel.com has seen sales double since its inception just 10 months ago. Soon, the online outlet plans to expand into brick and mortar stores with a new line of nickel free products for men, women, and children.

Posted by Industrial at 04:07 PM | Comments (0)

MedicTag, LLC Announces Expansion and Acquisition of Distributors for its New Medical Alert Product

MedicTags increased sales spurs expansion and optimistic outlook for this new company challenging the established medical alert industry.

(PRWEB) February 15, 2022 -- MedicTag, LLC a newly formed company in Deposit, NY is producing and distributing a patent pending USB (Universal Serial Bus) device that stores personal emergency information. The innovative device has the capacity to store and display critical information used by emergency personnel and can be carried on a key ring.

MedicTag was created by Edward Ricci, a disabled Vietnam veteran, to provide his elderly mother with a way to carry all her emergency information, medical conditions, medications and emergency contacts with her at all times. It proved so popular with everyone who saw it that he partnered with Mark Tucker, a prominent local business owner to form a company, patent and distribute the device.

The company originally unveiled the product last October at the National EMS Expo in Atlanta, Georgia to an overwhelmingly positive response from EMS professionals and will be on display again this March at the EMS Today conference in Philadelphia, Pennsylvania.

The company began selling the device, simply called MedicTag, last fall and has been pleased to experience steadily increasing sales from the very beginning. The product uses a USB flash drive to store emergency information such as identification, existing medical conditions, medications, doctors, surgeries and emergency contacts. MedicTag uses a simple software menu that makes it very user friendly and the device will work with any USB-capable computer.

Medical bracelets, ID tags and jewelry are routinely looked for by EMS personnel and first responders to determine a patient's special medical needs. MedicTag is hoping that its USB device will establish a leading presence within the industry because unlike the bracelets that offer just an alert of a medical condition, the new product will provide detailed emergency medical information a patient. Information that is essential to rapid diagnosis and proper treatment of a patient in a life threatening situation.

The company said the device will be of particular value to first responders because they will be able to insert the USB drive into any computer, many EMS units now have laptop computers in their vehicles, and immediately gain access to a person's emergency information even if the patient is unconscious. Changes to the information stored on the device can be made quickly and easily, whenever necessary, allowing the information to always be kept up to date.

Since many of those that have the greatest need for this device are on limit or fixed incomes, the company has made every effort to keep the price to a minimum. At $39.95, available locally and through on-line stores, they provide safety and security at an affordable price.

MedicTag has recently acquired new distributors in the US and is negotiating with distributors in Canada and the UK. The company has plans to translate the software for distribution in predominantly Spanish speaking counties and hopes that continued increases in sales will allow it to expand, providing what may be a life saving service to people worldwide. The company said expansion would increase its work force requirements, providing sorely needed jobs in the upstate New York area.

MedicTag, LLC is a privately held company located in Deposit , New York.
http://www.medictag.com

Posted by Industrial at 02:39 PM | Comments (0)

February 14, 2022

Howard Industries Medical Technology Division Unveils its Integrated Point of Care Cart at HIMSS Conference

Howard Industries® Medical Technology Division unveiled a prototype of its latest product offering — a sleek, ergonomically-designed point of care cart — today at the 2005 annual Healthcare Information and Management Systems Society (HIMSS) conference in Dallas, TX. With an 18” x 19” base, durable work surface, integrated cable management system, and high-performance 35Ah power system, the point of care cart will support a wide range of computing devices including barcode scanners, notebooks, tablets, and small form factor PCs

(PRWEB) February 14, 2022 -- “By scaling down the size of a traditional cart without sacrificing any necessary features, our design team has clearly created a product that is unique to the market,” said Everett E. “Robbie” Robinson, IV, Howard Industries Marketing Communication Manager. “It is quiet, easy to navigate, and can be used while sitting or standing thus making it ideal for any healthcare environment.”

Howard Medical Technology will continue to offer carts from its strategic partners as well as the innovative technology from its sister division, Howard Computers.

About Howard Industries Medical Technologies Division
Howard Medical Technology is a division of Howard Industries, a 500-million dollar, privately-held company headquartered in Laurel, MS. Like its sister divisions, Howard Transformers, Howard Ballast Products, and Howard Computers, Howard Medical Technologies is committed to creating, providing, and supporting superior products and services that meet or exceed the needs of its customers.

About Howard Computers
In addition to over 190,000 different product offerings ranging from laptops, desktops, servers, networks, and networking services that satisfy the demands of every home or business to rugged notebooks and mobile medical carts that enable healthcare personnel focus on patient care with confidence and fewer medical errors – Howard Computers provides tomorrow’s technology today. Visit www.HowardComputers.com/pr to find the solutions you’ve been missing.

Posted by Industrial at 12:48 PM | Comments (0)

February 13, 2022

ProSalesLaunch© Prepares Pharmaceutical Sales Representatives for Product Launch

Targeted training program provides essential selling, planning, and strategic skills representatives need to successfully launch and sell pharmaceutical products.

Downingtown, PA (PRWEB) February 13, 2022 -- S. R. Ware Associates, Inc. (SRWA) announces the development of ProSalesLaunch©, a new and unique sales training course designed to teach and prepare pharmaceutical sales representatives how to successfully launch a product in their territory. Pharmaceutical companies spend a great deal of time and money preparing for a product launch and do very well training representatives on product knowledge. Where some representatives need assistance is with territory focused planning and strategy.

SRWA’s new sales training program, ProSalesLaunch©, instruct representatives on:
• How to prepare for a new product launch,
• How to overcome objections,
• Identifying likely users,
• Planning and scheduling,
• Strategy and tactics for beating the competition, and
• Other topics focused on a successful launch from the representative’s perspective.

“Launching a new product is very exciting and can be challenging,” says Steve Ware, President, S. R. Ware Associates, Inc. “We want to prepare sales representatives for the launch of a new product while maintaining the proper balance with existing products.”

"Company sales training usually will cover only product knowledge and the appropriate use of literature," Ware says. “In our experience, representatives may know WHAT to do with a product launch, but not HOW to do it best. We go the extra step by actually teaching representatives how to prepare a winning product launch campaign.”

ProSalesLaunch© seminars are one or two day programs conducted by experienced SRWA professionals. In most cases, the best venue will be during district or regional meetings; however, some companies may prefer to use ProSalesLaunch© during national sales meetings. SRWA will “train the trainers” or assist company trainers in presenting the material. Each ProSalesLaunch© seminar participant is provided with a comprehensive training manual.

SRWA believes small to mid-size pharmaceutical companies that are six to 12-months away from a new product launch will receive the most benefit from SRWA’s experienced trainers and consultants. “This is an innovative concept,” says Ware. “Targeted training, above and beyond product knowledge, can enhance the launch of any new product.”

About ProSalesLaunch©
ProSalesLaunch© is available from S. R. Ware Associates, Inc. as either a “train the trainers” program or as a program led by SRWA experienced professional trainers. To find out more about SRWA training concepts, cost, delivery times, or customized seminars, call 610-321-6191 or e-mail SRWA

About S. R. Ware Associates, Inc.
S. R. Ware Associates, Inc. (SRWA) opened its doors in 1995 as a contract consultant group focused on pre- and post-launch pharmaceutical, biotechnology, or laboratory products requiring approval from Medicaid, Medicare, or other entities. SRWA President and founder Steve Ware is a 25-year veteran of pharmaceutical sales, market research, knowledge management, and opinion leader development. SRWA draws upon a cadre of experienced associates with expertise in lobbying, sales management, advocacy, and a variety of therapeutic areas. More information about SRWA is available by visiting http://www.srwa.net

Posted by Industrial at 10:40 AM | Comments (0)

February 12, 2022

Renowned Surgeon and Author Named as Medical Director for ReNu Medical

ReNu Medical, a leader in medical device reprocessing, announced today that Robert Landerholm, MD has accepted the position of Medical Director.

Everett, WA (PRWEB) February 12, 2022 -- “We were looking for the most qualified individual to manage a very important position in our company, and I believe we found him. As our new Medical Director, Dr. Landerholm is a fantastic fit and will play an integral role as our company continues to expand operations in the US and worldwide,” said Randy Long, CEO of ReNu Medical.

“I have a responsibility as medical director to insure ReNu employees are working in the safest environment possible and our reprocessed devices continue to be the safest available for the patient, as well as the hospital staff,” said Dr. Landerholm.

“When I first heard about ReNu Medical and toured their laboratory I was very impressed. ReNu is ahead of the curve, with a progressive technology and approach that is essential in our present medical environment. ReNu continues to prove its attention to detail which is supported by their recent FDA inspection in January 2005,” Dr. Landerholm said.

“ReNu has always been a clinically based operation. The safety of the patient, hospital staff and our employees are the foundations of ReNu,” said Bruce Pierson, COO.

Dr. Landerholm said, “I look forward to the opportunity of educating my peers, the healthcare community and the public on the advantages of high-level disinfection versus toxic EtO sterilization. It is important to understand High-level disinfection reprocessing of single use devices (SUD’s), when compared to current sterilization practices, increases hospital savings in an environmentally responsible manner, while reducing medical waste.”

“Dr. Landerholm brings to ReNu a caliber of expertise not found in other companies. Hospitals now have another reason to implement medical device reprocessing with ReNu Medical,” said Loren Timmons, VP of Marketing and Business Development.

Dr. Landerholm completed undergraduate studies at Washington State University (Summa cum laude) and received his Medical Doctorate from the University of Washington, School of Medicine. Dr. Landerholm is certified by the American Board of Surgery, and is a Fellow, American College of Surgeons and SAGES. He is currently in private surgical practice and serves on numerous hospital committees including, Infection Control, Utilization and Management, Pain Management Ethics and Cancer Control. He has been a key note speaker and his last article, Changing Experience with Primary Hyperparathyroidism was published in the American Journal of Surgery.

About Renu Medical
ReNu Medical is the leading reprocessor of non-invasive single use medical devices (SUD’s). ReNú’s unique services focus on providing the safest product for the patient, reducing medical waste and significantly reducing supply costs by maximizing available savings.

ReNú’s unique focus on non and semi critical (single use) medical devices provides a significant source of cost savings with very little associated risk. These devices go ON the body not IN the body. High Level Disinfection (HLD) offers significant cost saving advantages over sterilization methods. For example, ReNú's non-toxic method of HLD has the proven ability to turn an individual medical device 2-3 times more than a sterilizing reprocessor. This equates to a 2-3 times cost savings. Additionally, with our quick turn around time, two weeks compared to 8-12 weeks, less inventory is required thus saving you even more money. Finally, ReNú has the proven lowest discard rate in the industry (less than 10% on average) allowing you to get more devices back. These advantages offer significant savings far above other reprocessors.

High-Level Disinfection technology is 100% non toxic, environmentally friendly and a safe gentle alternative for non and semi critical (single use) medical devices. HLD offers twice the life span and double the saving of toxic Ethylene Oxide Gas (EtO) utilized by sterilization reprocessor’s. No harmful air emissions are released into the environment and no chemical residue is left on the device. HLD is supported by the CDC, APIC, and other healthcare organizations.

ReNu Medical is a supporter and Champion of Hospitals for a Healthy Environment. We recommend you visit their website (www.h2e-online.org) to learn more about how to reduce hospital medical waste.

Posted by Industrial at 06:20 PM | Comments (0)

February 10, 2022

CitiHope Partnership Delivers $7 Million Medical Relief Shipment to Tsunami Survivors in Remotest Areas of Sri Lanka

CitiHope founder credits partnership with BAPS Care International, International Relief Foundation and World Children’s Fund for success of massive aid delivery.

(PRWEB via PR Web Direct) February 10, 2022 -- CitiHope International (www.citihope.org), one of the most efficient humanitarian relief and development NGOs, joined with three partner relief organizations in announcing the delivery of $7 million of urgently-needed medicines and medical supplies to stricken tsunami survivors in northern and eastern Sri Lanka. The relief shipment was one of the largest ever undertaken by CitiHope, bringing hope and critical medical relief to the most difficult to reach and hardest-hit regions of the country.

"I have never seen such devastation," said CitiHope Senior Vice President and head of its in-country relief team, Paul Moore II. "The areas where we targeted our relief are in parts of Sri Lanka that had a weak infrastructure to begin with. The tsunamis totally wiped out what little medical infrastructure there was."

Moore said 3 major hospitals and 29 satellite health clinics were destroyed in these areas, leaving the survivors with few options for treating disease. CitiHope’s relief efforts are now focused on rebuilding the medical infrastructure in these remote areas and re-establishing the critical medical services they provide, as CitiHope has done in other regions of Asia and elsewhere around the world. To undertake these additional relief efforts, CitiHope is accepting donations online at www.citihope.org or by phone (845) 676-4400.

CitiHope founder, Rev. Paul S. Moore, expressed his deep gratitude to relief partners BAPS Care International (www.bapscare.org), an international social service charity based in Metuchen, New Jersey, International Relief Foundation (IRF) (www.irfonline.org), a charity based in Columbus, Ohio, and World Children’s Fund (WCF) (www.worldchildrensfund.net), a non-profit children’s relief organization based in San Jose, California.

"I cannot say enough about the partnership which has developed," said Rev. Moore. "Working together we delivered a major relief shipment to some of the most difficult to reach corners of Sri Lanka. We are grateful to our partners BAPS Care, IRF and WCF. Together, our timely response is making an enormous impact."

Mr. Kanu Patel, Chief Executive Officer of BAPS Care International, echoed Rev. Moore’s praise for the partnership. "Our organization has a long involvement with many of the communities ravaged by the tsunami waves. We are pleased that our support enabled CitiHope to ease the suffering of the victims in Sri Lanka."

"IRF is glad to have assisted CitiHope in delivering this critical relief shipment," said Mr. Ranjan Manoranjan, IRF Trustee and Co-Founder, returning Rev. Moore’s praise for the smooth operation. Mr. Jay Jayanthan, Trustee and Co-Founder at IRF, accompanied the team in Sri Lanka, providing valuable local knowledge and expertise.

Doctor Joseph Lam, WCF Chairman and Founder, is also an enthusiastic supporter of this partnership mission. "WCF is proud to have played a role in supporting the CitiHope delivery. There is, of course, still much to be done in the region, and more assistance will be needed."

About CitiHope International:
CitiHope International is one of the world’s premier Christian humanitarian relief and development organizations. Working in conjunction with private pharmaceutical donors, international organizations, the US Department of State and USAID, it has distributed $450 million of medical supplies to dozens of countries on 5 continents in the past 15 years. It has distributed more of its revenue as actual aid programs than any other organization in its class over the last 3 fiscal years according to Ministry Watch Sector Reports. CitiHope is a USAID-registered and certified non-profit 501(c)(3) organization.

About BAPS Care International:
BAPS Care International is a 501(c)(3) registered nonreligious, nonprofit international public charity organization committed to serving the world by caring for individuals, families and communities. It was registered as an independent charity in 2000 after serving 50 years under the wing of its parent organization, BAPS Swaminarayan Sanstha, founded in 1907.

About International Relief Foundation:
International Relief Foundation was formed at the height of Sri Lanka’s civil war in 1997 to help civilians affected by the war in Sri Lanka. The organization has funded numerous rehabilitation projects in the northeastern region of Sri Lanka through local charities and other social organizations including children’s orphanages and homes for the elderly. International Relief Foundation is a US IRS approved 501(c)(3) charitable organization.

About World Children’s Fund:
Founded by visionary leader Doctor Joseph Lam in 1993, World Children’s Fund is a global network of caring and sharing to help rescue needy children who are abandoned, distressed, endangered, exploited, homeless, hungry, sick or suffering. From its headquarters in San Jose, California, WCF disburses aid through its Global Care and Share Network, a collective effort of child care program providers and World Children’s Fund charities in 12 support countries.

PR Contact:
Don Wahlig, Wahlig Public Relations
Summit, New Jersey
(908) 790-9280 www.wahligpr.com

CitiHope International Contact:
Rev. Paul S. Moore, President
PO Box 38 Andes, NY 13731
(845) 676-4400 www.citihope.org

BAPS Care International Contact:
Shailendra Adroja
Manager Development & Operations
195 Main Street, Suite # 304
Metuchen NJ 08840
(732) 744-9734 ext. 109 www.bapscare.org

International Relief Foundation Contact:
Mr. Ranjan Manoranjan
Founder and Trustee
P.O. Box 20691
Columbus, OH 43220
(614) 832-2010 www.irfonline.org

World Children’s Fund Contact:
Bill Bray
International Communications Director
5442 Thornwood Drive
San Jose, CA 95123
(434) 466-3448 www.worldchildrensfund.net

Posted by Industrial at 01:53 PM | Comments (0)

Iverson Sponsors Governor's Trade Mission

Iverson Language Associates, Inc. will be sponsoring Wisconsin Governor Doyle's Trade Mission to Mexico

(PRWEB) February 10, 2022 -- Iverson Language Associates, Inc., is one of several companies who are sponsoring Governor Doyle’s upcoming Trade Mission to Mexico. The trade mission, which will focus on the agricultural market, will take place from March 6-11, 2005. Destinations include Mexico City and Guadalajara, where participants will have the opportunity to meet with business contacts, government leaders and potential customers.

As a sponsor, Iverson will provide translation services to the state of Wisconsin, helping to facilitate communication between participating Wisconsin companies and their counterparts in Mexico.

“Mexico is an important market for Wisconsin companies, and we’re proud to assist them in developing their export business” stated Steve Iverson, President.

The mission will be coordinated by the Departments of Commerce and Agriculture, Trade and Consumer Protection. For further information on the trade mission, contact Jennifer Winner at the Department of Commerce, telephone 608-266-0413.

Headquartered in Milwaukee, Iverson Language Associates, Inc. provides strategic solutions for managing document translation. For more information please visit the Iverson website at www.iversonlang.com, or contact Steve Iverson, President.

Posted by Industrial at 11:36 AM | Comments (0)

February 07, 2022

Physician Micro Systems, Inc. Signs Agreement to Connect to SureScripts Network for Electronic Prescribing

SureScripts’ network to enable nearly 3,500 physician users to exchange prescription data electronically with more than 85% of US pharmacies

Seattle, WA (PRWEB) February 7, 2022 -- Physician Micro Systems, Inc. (PMSI), a leader in the development of electronic health records (EHR), practice management, and computerized physician order entry (CPOE) software, and SureScripts, the nation’s largest network provider of electronic prescribing services, have announced an agreement to connect PMSI’s EHR clinical solution, Practice Partner® Patient Records, to the SureScripts network.

SureScripts will work with PMSI to certify Practice Partner Patient Records for connection to the SureScripts network. The SureScripts certification process involves several important steps, including integrating the SureScripts network with PMSI’s EHR solution, extensive testing of the system to ensure the successful transmission of electronic prescriptions, and a commitment to SureScripts’ business rules that, among other things, prohibit commercial messaging at the point of care. The neutrality of the SureScripts network protects a physician’s choice of therapy and a patient’s choice of pharmacy.

Once certified, the network connection will enable the nearly 3,500 physicians using PMSI’s EHR solution, which includes an electronic prescribing module, to exchange prescription data with pharmacies active on the SureScripts network. SureScripts has already certified the software of pharmacies and pharmacy technology vendors representing more than 85% of the nation’s pharmacies.

Andrew G. Ury, M.D., President/CEO of PMSI noted, “Our agreement to connect to the SureScripts network for electronic prescribing continues our long-standing commitment to help physicians improve the productivity and quality of care by employing advanced technologies in a clinical setting.”

“It’s exciting to work with an established provider of electronic health record systems like PMSI, who recognizes the importance of true electronic prescribing in a clinical environment,” explained Kevin Hutchinson, SureScripts’ President and CEO. “By connecting to the SureScripts network, PMSI will enable thousands of physicians to increase office efficiency, save time and, most important, improve patient safety.”

About Physician Micro Systems, Inc.
Founded in 1983 by Andrew G. Ury, M.D., Physician Micro Systems, Inc. (PMSI) is the creator of the Practice Partner® line of electronic health record (EHR), practice management system (PMS), and computerized physician order entry (CPOE) software applications for ambulatory care practices. PMSI is grounded in the daily reality of providing mission-critical clinical and administrative systems for thousands of physicians and their staff. PMSI has succeeded through a strong focus on the ambulatory care market combined with technology, leadership, and vision. Practice Partner applications are used nationwide by approximately 1,300 practices of all sizes and specialties, from solo-practitioners to large, enterprise, multi-site practices. More information about Physician Micro Systems, Inc is available at http://www.pmsi.com/.

About SureScripts
SureScripts, the largest network provider of electronic prescribing services, is committed to building relationships within the healthcare community and working collaboratively with key industry stakeholders and organizations to improve the safety, efficiency and quality of healthcare by improving the overall prescribing process. At the core of this improvement effort is SureScripts network, a healthcare infrastructure which establishes electronic communications between pharmacists and physicians and enables the two-way electronic exchange of prescription information. More information about SureScripts is available at www.surescripts.com

Posted by Industrial at 05:44 PM | Comments (0)

February 06, 2022

New Funding Code for EasyStand & Ovation Standers

In 2004, Altimate Medical Inc. received notification from the HCPCS National Panel announcing that code modifications to the level II set of code categories was made in response to Altimate Medical’s code application. The following new HCPCS Code, E0637, is to be used for identification of both pediatric & adult EasyStand & Ovation standing frames.

(PRWEB) February 6, 2022 -- HCPCS Code: E0637 Short Description: Sit- Stand w/ seat lift Long Description: Combination sit to stand system, any size, with seat lift feature, with or without wheels.

The use of E0637 has increased during 2004 with many private and public funding sources utilizing the new HCPCS codes. However, during this coding transition, it remains crucial that suppliers confirm the identifying code for sit to stand standing devices with each of their funding sources.

In addition to using the correct code, it is also important to have the proper documentation when applying for funding. Writing a good letter of medical justification and defining the client’s medical necessity, can directly affect whether or not funding is approved. Nancy Perlich, Reimbursement Specialist at Altimate Medical states "With the implementation of HIPPA and the challenges of coding, manufactures, suppliers and medical professionals must continue to advocate with the consumer to ensure access of appropriate assistive technology that allows for function and independence."

For more information on coding, documentation or the funding process, please call our funding hotline at 877-844-1172 or visit http://easystand.com/funding.

Note to Editors: Other Altimate Medical press releases and background information are available at http://easystand.com/pressroom

Posted by Industrial at 08:16 PM | Comments (0)

February 05, 2022

BodyLinx Bracelets “Irresistibly Magnetic” to Shoplifters Suffering from Arthritis

"Irresistibly Magnetic" is the tagline used to describe BodyLinx, a line of budget-friendly magnetic jewelry. The bracelets are turning out to be irresistible to shoplifters who are looking for relief from the pain of arthritis.

Beaverton, OR (PRWEB) February 5, 2022 -- According to Tom Frost, who lists himself as the company’s “magnetic conductor,” the bracelets are being stolen from some urban stores among the over 350 retailers featuring the line. “Ever since that British Medical Journal report came out about the benefits of magnetic bracelets, we’ve been swamped with orders,” says Frost. “But retailers are telling us stories about the bracelets being stolen by those who don’t have access to medication for their arthritis.”

According to the BMJ report, magnetic bracelets can significantly reduce the pain of arthritis. One in three American adults suffers from some form of the disease, and Vioxx, a widely-prescribed pain medication, was recently removed from the market after reports indicated it may lead to an increased risk of heart attack and stroke. Arthritis sufferers are left looking for alternative ways to deal with their discomfort.

Some retailers have taken measures to protect the bracelets from those who might be tempted to try them without paying. “Managers are setting them up behind the counter or inside a glass case, but that’s not how we envisioned the bracelets being sold,” says Frost, who describes his product as “just a fun jewelry item” without emphasizing the possibility of health benefits. He’d prefer to have the bracelets out so customers can try them on and play with them.

Because BodyLinx jewelry is made up of individual magnets that can be rearranged to form new styles, Frost opted to sell his bracelets in blister packs to keep the magnets together and prevent the bracelets from sticking to other metal items nearby.

“We thought we’d anticipated the challenges of selling magnets,” says Frost. “Honestly, we expected the biggest issue to be kids playing with them at school. We never thought people suffering from arthritis pain would be stealing them.”

Frost is now considering new packaging and display options for his jewelry. “I’m glad that so many people are finding the bracelets therapeutic, but frankly, this is giving me a headache.”

Posted by Industrial at 10:36 AM | Comments (0)

Medical Indicators Inc. Promotes Mercury Reduction

Makers of NexTemp® and TraxIt® join the fight to dispose of toxic thermometers.

Pennington, NJ (PRWEB) February 5, 2022 -- Medical Indicators Inc., makers of the mercury-free disposable thermometers NexTemp® and TraxIt®, has joined the nationwide movement to eliminate glass thermometers in the home, to reduce the risk of mercury contamination.

“NexTemp® and TraxIt® Thermometers are the Next Generation in Clinical Thermometry” according to John Romano, VP of Sales for Medical Indicators. “They are accepted around the world as accurate, safe, non-toxic thermometers and a perfect alternative to glass mercury and electronic thermometers.”

Medical Indicators has produced custom thermometers for organizations such as the National Institute of Health (NIH) and Marquette County Solid Waste for distribution at mercury exchange programs held across the United States. These programs encourage residents to hand in their old mercury thermometers in exchange for a brand new replacement thermometer.

Medical Indicators now offers a non-mercury, reusable thermometer for home use.

NexTemp® Reusable and Disposable Thermometers are accurate and easy to use. They are convenient, versatile and require no special storage conditions. NexTemp® Reusable and Disposable Thermometers are non-toxic, hygienic and economical.

For more information or samples of the NexTemp® Thermometers please contact Chris Illuminati at (888) 930-4599 Ext. 202

Posted by Industrial at 10:35 AM | Comments (0)

February 04, 2022

European Non-Prescription Medicines and OTC Self-Medication Markets Entering a Period of Rapid Change

Dublin--Research and Markets (researchandmarkets.com/reports/c12488) has announced the addition of OTC Distribution in Europe, The 2005 Edition – Embracing Change to their offering.

(PRWEB) February 4, 2022 -- The 2005 edition of OTC Distribution in Europe is the fifth edition of a major industry report published every two years that has been tracking the unfolding themes of change affecting the European market for non-prescription and OTC medicines.

The 2005 edition of the OTC Distribution in Europe study builds on over 10 years of research into the European market for non-prescription-classified, OTC medicines and associated consumer healthcare products. Over these years a number of important themes have emerged and grown to become the key drivers of the industry today.

The European non-prescription medicines and OTC self-medication markets have now entered a new period of rapid change that will unfold over the next two to three years. Deregulation of distribution channels, continuing de-reimbursement on a large scale, abandonment of resale price maintenance, concentration of wholesaler networks, emergence of pan-European pharmacy chains are among the main change drivers. Yet, competition from outside the pharmacy supply chain is also gathering pace with the expansion of general sale lists (GSL) providing the opportunity for the mass-market and a European Court ruling legitimising Internet and mail order services for OTC pharmaceutical products. Standard retail pricing for brands is also under pressure from private label products and undercutting by the rapid growth of Internet pharmacies.

Also of major importance is a trend in response to both internal and external competition of pan-European retail pharmacy groupings, which are emerging across the European region either as real or 'virtual' chains and pharmacy symbol groups.

While it is abundantly clear that the market place for consumer healthcare today is much different from that of the over regulated pre-prescription to OTC era of 1992, what is less clear is the amount of change that has occurred since the 2002 edition of OTC Distribution in Europe. This as this study shows has been both considerable and highly significant.

The purposes of this important study therefore, are to identify the main themes driving change in the channels through which non-prescription and OTC medicines and associated self-medication products are distributed and to explore and explain the opportunities and challenges that they present to suppliers in the future.

Since the first edition in 1992, the report has been expanded to an 18-country study. However, this latest edition would be incomplete without discussion of the implications of the accession of the new states to the European Union in 2004 and in particular those of Northern, Central and Eastern Europe. While Poland, Hungary, Czech Republic, Slovakia and Slovenia featured in the 2002 edition, Estonia, Latvia and Lithuania are discussed briefly in outline in this the latest edition.

Among some of the key issues identified in the report are:
- Radical reforms of reimbursement for non-prescription and OTC medicines, pharmacy establishment and the abolition of retail price maintenance for OTC medicines, especially in Germany in 2004, and their implications for the non-prescription and OTC self-medication industry as a whole
- The rapid growth of large ‘virtual’ pharmacy chains or pharmacy symbol groups especially in Germany, Switzerland and the Netherlands coupled with their moderate growth in the UK and their emergence in Italy and the Nordic and Baltic region and the way these are concentrating buying power across Europe
- Implications of the concentration of pharmaceutical wholesaler’s buying power across European borders and vertical integration into retailing
- Accession of Poland, Czech Republic, Slovakia, Hungary and the Baltic States into the European Union in 2004 and the challenges and opportunities these new markets present to Europe’s consumer healthcare manufacturers, pharmaceutical wholesalers and pharmacies and general retailers
- A gradual deregulation of the pharmaceutical supply chain especially pharmacy geographic density and ownership rules
- The expansion of general sale lists (GSL) for OTC medicines and the attraction of self-medication to supermarket chains in Europe
- The significance of the Internet Pharmacy as an evolving distribution channel but more significantly as a major agent of change

For more information visit http://www.researchandmarkets.com/reports/c12488

Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980

Posted by Industrial at 04:10 AM | Comments (0)

February 02, 2022

Galvanon Adds Three MediKiosk™ Way Finding Software Solution Customers

Hospital kiosks will provide new customers unequaled patient self-service capabilities.

Maitland, FL (PRWEB via PR Web Direct) February 2, 2022 -- Galvanon, the patient experience company, today announced the future placement of hospital kiosks in three quality healthcare institutions across the nation. John C. Lincoln Health Network (Phoenix, Ariz.), Methodist Hospital of Southern California (Arcadia, Calif.) and Riverside Regional Medical Center (Newport News, Va.) have selected the MediKiosk™ Enterprise Way Finding software solution as part of their system-wide initiatives to improve satisfaction and enhance the patient experience.

“We chose Galvanon because their technology provides us with a strategic roadmap for providing the best possible experience for all of the individuals that use our facilities, including patients, their families and their friends, both now and in the future,” said Robert Israel, chief information officer at John C. Lincoln Health Network. “Our organization understands the value of building long-term relationships with our customers, and the added convenience that this technology provides puts us one step closer to achieving this goal.”

Powered by Galvanon’s state-of-the-art software, the self-service hospital kiosks will allow visitors to view and print directions to locations within the hospital’s multiple facilities. This information can also be accessed on PCs by volunteers and staff to print easy-to-read directions. When the kiosks are not providing directions, they can be used to communicate the organization’s key messages and other content.

“By teaming with Galvanon, we’re introducing the next generation of care to our community,” said Kelly Linden, vice president of Methodist Hospital of Southern California. “In a competitive market like ours, having state-of-the-art equipment and world-class physicians is critical, but not always enough. We believe the next generation of care will require us to extend beyond the traditional boundaries of hospital services. Galvanon allows us to deliver the type of patient experience that will truly differentiate us in the local marketplace.”

Galvanon’s MediKiosk Enterprise Way Finding solution is part of a comprehensive suite of products that allows hospitals and clinics to provide patient self-service capabilities such as check-in, on-line BillPay and pre-registration via the Web.

“We are pleased to add these health systems to our growing list of clients,” said Chakri Toleti, president of Galvanon. “Our self-service solutions are a perfect complement to their existing patient satisfaction initiatives.”

About Galvanon, Inc.
Galvanon helps healthcare organizations enhance the patient experience at home, in the hospital and in the physician’s office through innovative solutions such as hospital kiosks, Web self-service applications, software and technology that streamlines everyday interactions and improves patient flow through the healthcare process. For more information, visit www.galvanon.com/healthcare.

Press contact:
Cathi Hilpert
407-667-0669

Sales Contact:
Gary Anthony
817-832-1060

Posted by Industrial at 02:54 PM | Comments (0)

Probiotic Sore Throat Treatment Leads to Bad Breath Cure

New probiotic treatment stops bad breath.

Los Angeles, CA (PRWEB via PR Web Direct) February 2, 2022 -– A clinically-proven probiotic treatment that prevents sore throats has surprisingly provided a long term cure for bad breath. Researchers at Otago University in New Zealand, using a patented strain of Streptococcus salivarius (strain K12) found that subjects in several clinical studies supporting the benefits of using “good” bacteria to fight the “bad” bacteria causing sore throats, also discovered that they no longer had any bad breath.

The probiotics, known as Atkiv-K12, produce a simple protein called BLIS (Bacteriocin-Like Inhibitory Substance) that prevents certain bad bacteria from growing in the same environment. In the U.S., Dr. Harold Katz, founder of The California Breath Clinics, has recently completed studies on roughly 1,000 subjects with a 97% success rate in eliminating bad breath, as well as dry mouth, and taste disorders in even the most severe cases of Halitosis.

Test subjects first created a “level playing field” by rinsing with an oxygenating oral rinse (AktivOxigen Serum) followed by a mouthwash made with Aktiv-K12, daily for 30 days. The Aktiv-K12 rebalanced the oral micro flora preventing anaerobic sulfur-producing bacteria from overtaking the tongue, throat, and tonsils, where most bad breath originates. In order to maintain a healthy oxygenated oral environment, allowing the good bacteria to thrive, simply required rinsing and brushing with oxygen-releasing oral products (TheraBreath brand). However, those subjects returning to alcohol based mouthwash or toothpaste, containing sodium lauryl sulfate, did not maintain a healthy population of the good bacteria.

Katz, who holds both a degree in Bacteriology and Dentistry (both from UCLA), states that Aktiv-K12 therapy may preclude surgery or other invasive therapies for oral problems. He and his associates are close to finding cures for tooth decay and gum disease using Bacteriotherapy.

The TheraBreath brand of Aktiv-K12 Probiotic System, classified as "an all-natural" approach to long-term fresh breath and oral health is now available directly to the public worldwide, through Dr. Katz’s clinics and website www.drkatz.com or www.freshbreath.com or by calling 1-800-973-7374.

Detailed scientific information about Aktiv-K12, bad breath, dry mouth, and oxygenating TheraBreath home therapies are available at http://www.aktivk12.com or http://www.therabreath.com.

Contact:
Mark Fiala
Dr. Harold Katz, LLC
Phone Number: 323-933-7225
http://www.aktivk12.com

Posted by Industrial at 02:53 PM | Comments (0)

February 01, 2022

B2B Marketing Health and Elder Care Services

Reaching the Decision Makers of the Healthcare and Elder Care Industry

(PRWEB) February 1, 2022 -- Quality Care Options is an established company advocating for the right of all seniors to receive excellent service and product. The organization recommends Certified Senior Approved Services to its elderly clientele. Through its highly visible web sites and monthly ezines, Quality Care Options (QCO) attracts both the senior and the businesses that serve the senior population.

Barbara Mascio, Founder of QCO, has been inundated with requests from healthcare businesses for recommendations towards resources that would further promote an elder or healthcare related business. These requests include; ‘Who should I call for the best liability insurance coverage?’ ‘Who do you recommend as a resource for market analysis?’ ‘How do I start an elder care business?’ and even ‘Who can handle our maintenance and lawn care?’

“Every business serving our senior population needs resources towards recruitment, security checks, lead generation and advice on marketing how-to’s and so we’ve provided a very affordable method for businesses offering these products, services and resources to reach our web site visitors”, states Barbara. Not all advertising will be accepted. You must first submit your banner or text by following the guidelines found on http://www.qualityeldercare.com/advertising

Speakers and professional networking groups are offered special low rates of just $10 per month for an ad with a hyperlink to their web. Businesses to Business advertising can be purchased for as little as $20 a month. “We’re not trying to make a living from advertising revenue, that’s not what this is all about, states Barbara. We simply want to cover the administrative costs and provide our web visitors the resources they need to further grow their business.”

For businesses marketing directly to the senior citizen, please see http://www.qualityeldercare.com/providers to review how to apply for Senior Approved Certification as no advertising is accepted for this segment of our business.

Advertising on the Internet can be a crapshoot. You should do your homework before spending any amount of money. Does the web site have enough unique visitors each day interested in the service you offer? One site to check traffic stats on line is http://www.alexa.com Simply enter the url address of any web site to review certified traffic results. Obviously, you want a site to have higher web traffic than your own, or at the very least, equal to your traffic.

Posted by Industrial at 05:03 PM | Comments (0)

Announcing the Spazz-G, by Colours Wheelchairs: No Compromise Necessary

Colours 'N Motion announces a 'breakthrough' wheelchair: The Spazz G. Designed to be lightweight, stylish and affordable, the Spazz G is the next innovation by Colours.

Corona, CA (PRWEB via PR Web Direct) February 1, 2022 -- Ultra-Light, Ultra-Hip, Ultra-Adjustable, Ultra-Durable, Ultra-Affordable, Ultra-Stylish, Ultra-COLOURS. The thought of a stylish and affordable wheelchair has been considered by many to be beyond dreams. Now Colours has changed this. The new SPAZZ-G is not only a totally adjustable and stylish wheelchair, but with a suggested retail price of only $1,450.00 in the USA and approximately euro1450 in Europe (final price to be determined) it is priced to be fully covered by most world-wide health payment plans.

The SPAZZ-G features expandable seat width and depth, as well as adjustable positioning. The contoured frame is designed to be not only stylish, but also practical since it is easy to pull into the car and over the steering wheel. At 19 lbs (8.6 kg), including wheels, it is sleek, lightweight and easy to lift.

The SPAZZ-G has a main rigid axle tube that gives durability, rigidity and support. It has positive locking adjustable backrest, offering a full range of infinite backrest angle settings.

But best of all, it is not one of those mass produced, ordinary wheelchairs. The SPAZZ-G is different, because it's a Colours Wheelchair. Celebrate life in a Colours Wheelchair.

About Colours:
Colours is a leader in the rehabilitation industry for its design of innovative everyday, sport and pediatric wheelchairs. Colours' wheelchairs are lightweight, adjustable and customizable. At 14.5 pounds (6.6 kg) the custom-designed Zephyr (http://www.colourswheelchair.com/products/prod_zephyr.htm) is one of the lightest wheelchairs on the market. The Boing! (http://www.colourswheelchair.com/products/prod_boing.htm) is the first wheelchair with four-wheel independent suspension. For more information: www.ColoursWheelchair.com. Colours is now expanding in Europe. European distributors interested in distributing Colours Wheelchairs are encouraged to contact Med Services Europe, Colours’ European representative.

About Med Services Europe:
Med Services Europe B.V. is based in Amsterdam, The Netherlands and conducts Sales, Marketing and Business Development services for the Pharmaceutical, Diagnostic and Medical Equipment Industry. Med Services' specializes in building and managing distribution networks for medical manufacturers in Eastern and Western Europe. We are Colours' Representative in Europe. European Wheelchair distributors are invited to contact us.

www.MedServicesEurope.com
Telephone: +31648566707

Posted by Industrial at 03:49 PM | Comments (0)